1-9 of 9 results
Webinar
We’ll analyze the American Rescue Plan and provide strategic guidance to institutions as they navigate the additional funds and stipulations.
Expert Insight
As institutional leaders develop diversity, equity, and inclusion (DEI) strategic plans, it’s important for them to consider how they frame their priorities and commitments. EAB reviewed over 40 DEI plans from institutions across the U.S., Canada, and Europe and found that many used generic and deficit-based language to articulate their priorities.
Expert Insight
Higher education is being asked to go further than ever to foster equity and dismantle systemic racism, but too few institutions have the accountability systems in place to facilitate follow through on their diversity, equity, inclusion, and justice (DEIJ) plans.
Resource
Schools are under growing pressure to increase space efficiency across the board. Learn how to increase lab space efficiency by optimizing initial allocations and using productivity metrics to fine-tune allocations over time.
Resource
These profiles provide a snapshot of the employer demand in each state to inform portfolio and program brainstorming discussions.
Expert Insight
At many institutions, living on campus is a crucial dimension of the student experience, as well as a key source of auxiliary revenue. But current public health evidence indicates that communal living could strongly facilitate virus transmission, and many campuses lack the ability to give each student the safest option of a private room and bathroom. Ultimately, all universities are facing the same question: what is the housing solution that provides students with an on-campus experience that’s as fulfilling as possible, while also protecting the community from outbreaks?
Expert Insight
On May 11th, the US Department of Education (ED) published their long-awaited funding allocations and guidance around the $39.6B allocated to the Higher Education Emergency Relief Fund (HEERF III) in the American Rescue Plan. ED’s new guidance builds upon their March 19th updated interpretation for HEERF II uses and lost revenue reimbursement.
Expert Insight
On December 11th, the US Food and Drug Administration (FDA) authorized emergency use of a vaccine to prevent the coronavirus strand behind COVID-19. This vaccine, developed by Pfizer Inc. and BioNTech SE, is the first one to have received full approval from the US regulatory body, and was approved by health authorities in the United Kingdom and Canada over the week prior.
Expert Insight
Use this guide to help you confidently lead dialogue across your institution and community and build a shared understanding of the change that is needed to create the anti-racist education institutions our society needs.
